Biography and Research Information
OverviewAI-generated summary
Edita M. Newton's research focuses on understanding the molecular mechanisms underlying skin diseases, particularly atopic dermatitis. Her work investigates the role of signaling pathways, such as the aryl hydrocarbon receptor/nuclear factor E2-related factor 2 (AHR/NRF2) pathway, as potential therapeutic targets for inflammatory skin conditions. Newton has also examined the dermatologic side effects of specific cancer therapies, including erdafitinib. Her scholarly output includes a publication co-authored with Vivian Y. Shi, exploring the AHR/NRF2 pathway's relevance to atopic dermatitis. Newton's academic contributions are reflected in a citation count of 35 and an h-index of 1.
Metrics
- h-index: 1
- Publications: 1
- Citations: 35
Selected Publications
-
Aryl hydrocarbon receptor/nuclear factor E2‐related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis (2022)
Collaboration Network
Top Collaborators
Jonwei Hwang
Illinois College (US)
1 shared publication
- Aryl hydrocarbon receptor/nuclear factor E2‐related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis
Jennifer L. Hsiao
University of Southern California (US)
1 shared publication
- Aryl hydrocarbon receptor/nuclear factor E2‐related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis
Vivian Y. Shi
University of Arkansas for Medical Sciences
1 shared publication
In database
- Aryl hydrocarbon receptor/nuclear factor E2‐related factor 2 (AHR/NRF2) signalling: A novel therapeutic target for atopic dermatitis
Megan K. Johnson
Indiana University School of Medicine
1 shared publication
- Adverse dermatologic effects of erdafitinib in a patient with metastatic urothelial carcinoma
Marie M Clark
Indiana University School of Medicine
1 shared publication
- Adverse dermatologic effects of erdafitinib in a patient with metastatic urothelial carcinoma
Carli P. Whittington
Indiana University School of Medicine
1 shared publication
- Adverse dermatologic effects of erdafitinib in a patient with metastatic urothelial carcinoma
Similar Researchers
Based on overlapping research topics
Abigale Clark
University of Arkansas for Medical Sciences
Dermatology and Skin Diseases
Immune Response and Inflammation
Cancer Treatment and Pharmacology
Henry K. Wong
University of Arkansas for Medical Sciences
Dermatology and Skin Diseases
Immune Response and Inflammation
Cancer Treatment and Pharmacology
Daphne Macbruce
University of Arkansas – Fort Smith
Dermatology and Skin Diseases
Immune Response and Inflammation
Cancer Treatment and Pharmacology
N. S. Kumar
University of Arkansas for Medical Sciences
Dermatology and Skin Diseases
Immune Response and Inflammation
Cancer Treatment and Pharmacology
Henry Ν. C. Wong
University of Arkansas for Medical Sciences
Dermatology and Skin Diseases
Immune Response and Inflammation
Cancer Treatment and Pharmacology
Wei Li
University of Arkansas for Medical Sciences
Dermatology and Skin Diseases
Immune Response and Inflammation
Cancer Treatment and Pharmacology